Egrifta, With Help From Patient Testimonies, Gets Advisory Committee Recommendation

Unanimous vote for Theratechnologies' HIV lipodystrophy drug by Endocrinologic and Metabolic Drugs Advisory Committee acknowledges need for post-marketing safety work.